Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Ending Cash Position : ¥972 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Zhejiang AngliKang Pharmaceutical Co Ending Cash Position?

Zhejiang AngliKang Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥972 Mil.

Zhejiang AngliKang Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2023 (¥983 Mil) to Dec. 2023 (¥853 Mil) but then increased from Dec. 2023 (¥853 Mil) to Mar. 2024 (¥972 Mil).

Zhejiang AngliKang Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2021 (¥688 Mil) to Dec. 2022 (¥729 Mil) and increased from Dec. 2022 (¥729 Mil) to Dec. 2023 (¥853 Mil).

Zhejiang AngliKang Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Zhejiang AngliKang Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang AngliKang Pharmaceutical Co Ending Cash Position Chart

Zhejiang AngliKang Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

450.56

846.91

687.58

728.90

852.61

Zhejiang AngliKang Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															663.58	693.38	982.57	852.61	971.92

Zhejiang AngliKang Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Zhejiang AngliKang Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	728.898	+	123.716
	=	853

Zhejiang AngliKang Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	852.613	+	119.311
	=	972

Zhejiang AngliKang Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Zhejiang AngliKang Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang AngliKang Pharmaceutical Co Ltd (SZSE:002940) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 1000, North Luzhou Avenue, Zhejiang Province, Quzhou, CHN, 312400

Website

http://www.alkpharm.com

Zhejiang AngliKang Pharmaceutical Co Ltd is engaged in the manufacturing and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The main products offered by the group are cephalosporins antibacterial, angiocarpy drugs and gastrointestinal tract drugs. Geographically, the activities are carried out through Shengzhou, China.

Executives

Pan Xiao Yun	Supervisors
Ye Shu Xiang	Director
Yang Guo Dong	Executives
Xu Ai Fang	Supervisors
Wu Zhe Hua	Director

Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Headlines

No Headlines